Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?-Reference-Cited by-同舟云学术

Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?

Published:2024-03-30 Issue:8 Volume:56 Page:2597-2605
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Porcaro Antonio Benito^ORCID,Bianchi Alberto,Panunzio Andrea,Gallina Sebastian,Serafin Emanuele,Tafuri Alessandro,Trabacchin Nicolò,Orlando Rossella,Ornaghi Paola Irene,Mazzucato Giovanni,Vidiri Stefano,D’Aietti Damiano,Montanaro Francesca,Brusa Davide,Patuzzo Giulia Marafioti,Artoni Francesco,Baielli Alberto,Migliorini Filippo,De Marco Vincenzo,Veccia Alessandro,Brunelli Matteo,Siracusano Salvatore,Cerruto Maria Angela,Antonelli Alessandro

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11255-024-04019-3.pdf

Reference36 articles.

1. Mottet N, Cornford P, van den Bergh RCN et al (2022) EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer. In: European Association of Urology. https://uroweb.org/guidelines/prostate-cancer. Accessed 5 Mar 2023

2. Schaeffer E, Srinivas S, An Y et al (2022) Prostate Cancer, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. In: National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 5 Mar 2023

3. Moyer VA (2012) Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 157:120–134. https://doi.org/10.7326/0003-4819-157-2-201207170-00459

4. Shah N, Ioffe V, Huebner T, Hristova I (2018) prostate biopsy characteristics: a comparison between the pre- and post-2012 united states preventive services task force (USPSTF) prostate cancer screening guidelines. Rev Urol 20:77–83. https://doi.org/10.3909/riu0793

5. Jani C, Mouchati C, Abdallah N et al (2022) Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/S41391-022-00628-0